XS
Xspray Pharma AB (publ)
XSPRAY.ST · STO
10.08 kr +0.20% (+0.02 kr)
1M -32.89%
Market Cap 477.0M kr
P/E Ratio -
Div. Yield -
ROE 26.00%
Bulios Fair Price
7.83 kr
22.3% downside
Trenutna cena
10.08 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XSPRAY.ST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.75x
P/E N/A
EV/EBITDA N/A
Growth
39 /100
Stable Book val. growth 2.83%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 18.00%
ROE 26.00%
Asset turnover 0.00x
Debt
61 /100
Moderate Debt/Equity 0.23x
Current ratio 1.39x
Int. coverage -6.05x
Stability
40 /100
Moderate Beta -0.03x
EPS volatility 39.72%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XSPRAY.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Blake Leitch
Employees
24
Headquarters
Solna
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report